Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy Sutherland

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
From methadone to Methadose: Lessons learned from methadone formulation change in British ColumbiaMatias Raski, Christy Sutherland, Rupinder Brar
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
Matias Raski, Christy Sutherland, Rupinder Brar
BMJ Case Reports|August 3, 2019
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorderRupinder Brar, Christy Sutherland, Seonaid Nolan
Canadian Family Physician Medecin De Famille Canadien|November 16, 2017
Does evidence support supervised injection sites?Jennifer Ng, Christy Sutherland, Michael R Kolber
Canadian Family Physician Medecin De Famille Canadien|February 18, 2022
Role of stimulant replacement therapy in treating stimulant use disorders: Within the context of the COVID-19 pandemicWilliam Mak, Devon Webb, Christy Sutherland, et al.
Drug and Alcohol Review|September 5, 2017
Challenges of treatment of acutely ill patients enrolled in a managed alcohol programMegan Hill, Sharon Vipler, Christy Sutherland, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 5, 2020
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case reportTyler Wilson, Rupi Brar, Christy Sutherland, et al.
Drug and Alcohol Review|July 14, 2020
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case seriesRupinder Brar, Nadia Fairbairn, Christy Sutherland, et al.
BMJ Case Reports|September 23, 2015
Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrestGeoffrey Walton, Seonaid Nolan, Christy Sutherland, et al.
Journal of Addiction Medicine|February 4, 2020
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case SeriesValerie Giang, Rupinder Brar, Christy Sutherland, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
From methadone to Methadose: Lessons learned from methadone formulation change in British ColumbiaMatias Raski, Christy Sutherland, Rupinder Brar
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
Matias Raski, Christy Sutherland, Rupinder Brar
BMJ Case Reports|August 3, 2019
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorderRupinder Brar, Christy Sutherland, Seonaid Nolan
Canadian Family Physician Medecin De Famille Canadien|November 16, 2017
Does evidence support supervised injection sites?Jennifer Ng, Christy Sutherland, Michael R Kolber
Canadian Family Physician Medecin De Famille Canadien|February 18, 2022
Role of stimulant replacement therapy in treating stimulant use disorders: Within the context of the COVID-19 pandemicWilliam Mak, Devon Webb, Christy Sutherland, et al.
Drug and Alcohol Review|September 5, 2017
Challenges of treatment of acutely ill patients enrolled in a managed alcohol programMegan Hill, Sharon Vipler, Christy Sutherland, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 5, 2020
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case reportTyler Wilson, Rupi Brar, Christy Sutherland, et al.
Drug and Alcohol Review|July 14, 2020
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case seriesRupinder Brar, Nadia Fairbairn, Christy Sutherland, et al.
BMJ Case Reports|September 23, 2015
Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrestGeoffrey Walton, Seonaid Nolan, Christy Sutherland, et al.
Journal of Addiction Medicine|February 4, 2020
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case SeriesValerie Giang, Rupinder Brar, Christy Sutherland, et al.
Pageof 4